Evidence map›Paper›PMID 21695018›Full record

ArticleDermato-endocrinology2011

The role of fatty aldehyde dehydrogenase in epidermal structure and function.

William B Rizzo

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Dermato-endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01971957 (Sjogren-Larsson Syndrome), which is not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01971957 completednot on this mapstarted 2013, after this paper: background citation

Sjogren-Larsson Syndrome: A Longitudinal Study of Natural History, Clinical Variation and Evaluation of Biochemical Markers

Typeobservational_patient_registrySponsorUniversity of NebraskaRan2013 to 2023Enrolled20ConditionsSjogren-Larsson Syndrome (SLS)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Impaired Skin Barrier Function Due to Reduced ω-Molecular and cellular biology · 2021
    Article
  2. Sjogren-Larsson Syndrome: Mechanisms and Management.The application of clinical genetics · 2020
    Review
  3. Article
  4. Article
  5. Epidermal barriers.Cold Spring Harbor perspectives in medicine · 2014
    Review
  6. Review
  7. Sjögren-Larsson syndrome in clinical practice.Journal of inherited metabolic disease · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

William B RizzoDepartment of Pediatrics; University of Nebraska Medical Center; Omaha, NE USA.
University of Nebraska Medical Center · US

Funding

ICHTHYOSIS IN SJOGREN/LARSSON SYNDROMER01AR044552 · NIAMS · VIRGINIA COMMONWEALTH UNIVERSITY · PI RIZZO, WILLIAM B. · 1997 to 2010
$3.6M
NIAMS NIH HHS R01 AR044552
6 · The paper itself

Abstract

The epidermal water barrier resides in the stratum corneum (SC) and is dependent on a highly organized network of multi-lamellar membranes comprised of a critical lipid composition. The SC membranes are formed from precursor membranes packaged in cytoplasmic lamellar bodies in the stratum granulosum and delivered to the SC by exocytosis. An abnormal lipid composition of the SC membranes often results in a disrupted water barrier and the clinical appearance of ichthyosis. This cutaneous feature is characteristic of Sjögren-Larsson syndrome (SLS), an inborn error of lipid metabolism caused by deficiency of fatty aldehyde dehydrogenase (FALDH). The contribution of FALDH to normal epidermal function has become increasingly evident with the recognition that this enzyme has an essential role in metabolism of several lipids, including fatty aldehydes and alcohols, ether glycerolipids, isoprenoid alcohols and certain lipids that undergo ω-oxidation, such as leukotriene B4 and very long-chain fatty acids. In the absence of FALDH, the skin produces lamellar bodies that are empty, lack their surrounding vesicle membranes or contain granular contents rather then the usual cargo membranes. These defective organelles also have impaired exocytosis, which results in structurally abnormal, deficient multi-lamellar membranes in the SC and a leaky water barrier. Although the exact biochemical mechanism for the cutaneous pathology is still unclear, studies in SLS demonstrate the critical importance of FALDH for normal epidermal structure and function.

Indexed as

epidermisfatty alcoholichthyosislamellar bodymembranesSjögren-Larsson syndromestratum corneum

Identifiers

PMID21695018
PMCPMC3117008
OpenAlexW2044035231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.